Vaccines – COVID19 Vaccine Tracker
Vaccines – COVID19 Vaccine Tracker


				

					Vaccines Candidates in Clinical Trials
					
				

			
			
				Phase 1: 
				66
				Vaccines
			
				Phase 2: 
				72
				Vaccines
			
				Phase 3: 
				92
				Vaccines
			
				Approved: 
				50
				Vaccines
			12 vaccines no longer progressingAbout Trial Phases Where are vaccines developed?92 Vaccines in Phase 3 Clinical Trials	
		
			
								Anhui Zhifei Longcom
				Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Anhui Zhifei Longcom
				Zifivax
			
		
		
	
	
		This vaccine is approved.	

	Approved in 4 countries		
			21 trials in 5 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Bagheiat-allah University of Medical Sciences
				Noora vaccine
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Biological E Limited
				Corbevax
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			7 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Center for Genetic Engineering and Biotechnology (CIGB)
				Abdala
			
		
		
	
	
		This vaccine is approved.	

	Approved in 6 countries		
			5 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Clover
				SCB-2019
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			15 trials in 13 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Codagenix Inc
				COVI-VAC
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			Live-Attenuated
		

		
	
		
		
			
								COVAXX
				UB-612
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			7 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								EuBiologics Co Ltd
				EuCorVac-19
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 3 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Instituto Finlay de Vacunas Cuba
				Soberana 02
			
		
		
	
	
		This vaccine is approved.	

	Approved in 4 countries		
			7 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Instituto Finlay de Vacunas Cuba
				Soberana Plus
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			5 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Jiangsu Rec-Biotechnology Co Ltd
				ReCOV
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			6 trials in 3 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Laboratorios Hipra SA
				COVID-19 vaccine HIPRA
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			10 trials in 4 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Livzon Mabpharm Inc
				V-01
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			7 trials in 3 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Medigen
				MVC-COV1901
			
		
		
	
	
		This vaccine is approved.	

	Approved in 4 countries		
			15 trials in 4 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Nanogen
				Nanocovax
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								National Vaccine and Serum Institute
				Recombinant SARS-CoV-2 Vaccine (CHO Cell)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			3 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				Bivalent SARS-CoV-2 rS Vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				Nuvaxovid
			
		
		
	
	
		This vaccine is approved.	

	Approved in 40 countries		
			22 trials in 14 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				NVX-CoV2515
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								PT Bio Farma
				IndoVac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			4 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								PT Bio Farma
				SARS-CoV-2 Protein Subunit Recombinant Vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			5 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Razi Vaccine and Serum Research Institute
				Razi Cov Pars
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			5 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sanofi/GSK
				Recombinant Protein
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			6 trials in 7 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sanofi/GSK
				SP/GSK subunit D614 vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sanofi/GSK
				VidPrevtyn Beta
			
		
		
	
	
		This vaccine is approved.	

	Approved in 30 countries		
			3 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Serum Institute of India
				COVOVAX (Novavax formulation)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 6 countries		
			7 trials in 3 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Shionogi
				S-268019
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			9 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sinocelltech
				SCTV01C
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			12 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sinocelltech
				SCTV01E
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			9 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								SK Bioscience Co Ltd
				SKYCovione
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			7 trials in 6 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Takeda
				TAK-019 (Novavax formulation)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								University Medical Center Groningen
				AKS-452
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Vaxine/CinnaGen Co.
				SpikoGen
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			8 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Vector State Research Center of Virology and Biotechnology
				EpiVacCorona
			
		
		
	
	
		This vaccine is approved.	

	Approved in 4 countries		
			4 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								West China Hospital
				Recombinant (Sf9 cell)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			9 trials in 5 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Yisheng Biopharma
				PIKA COVID-19 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Medicago
				Covifenz
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			6 trials in 6 countries		

		
		
			VLP
		

		
	
		
		
			
								Radboud University
				ABNCoV2
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 3 countries		

		
		
			VLP
		

		
	
		
		
			
								Yantai Patronus Biotech Co Ltd
				LYB001
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			6 trials in 1 country		

		
		
			VLP
		

		
	
		
		
			
								AnGes
				AG0302-COVID19
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			8 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Inovio
				INO-4800
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			10 trials in 9 countries		

		
		
			DNA
		

		
	
		
		
			
								Zydus Cadila
				ZyCoV-D
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			6 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								AIM Vaccine
				LVRNA009
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Arcturus Therapeutics Inc
				ARCT-154
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			6 trials in 3 countries		

		
		
			RNA
		

		
	
		
		
			
								CanSino Biologics Inc
				COVID-19 mRNA Vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Daiichi Sankyo Co Ltd
				DS-5670a
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			5 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gennova Biopharmaceuticals Limited
				GEMCOVAC-19
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1273.211
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1273.213
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1273.529
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1273.617.2
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				Spikevax
			
		
		
	
	
		This vaccine is approved.	

	Approved in 88 countries		
			70 trials in 24 countries		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				Spikevax Bivalent Original/Omicron BA.1
			
		
		
	
	
		This vaccine is approved.	

	Approved in 38 countries		
			5 trials in 4 countries		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				Spikevax Bivalent Original/Omicron BA.4/BA.5
			
		
		
	
	
		This vaccine is approved.	

	Approved in 33 countries		
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b1
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			5 trials in 3 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b2s01
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				Comirnaty
			
		
		
	
	
		This vaccine is approved.	

	Approved in 149 countries		
			100 trials in 31 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				Comirnaty Bivalent Original/Omicron BA.1
			
		
		
	
	
		This vaccine is approved.	

	Approved in 35 countries		
			3 trials in 5 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				Comirnaty Bivalent Original/Omicron BA.4/BA.5
			
		
		
	
	
		This vaccine is approved.	

	Approved in 33 countries		
			4 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Providence Therapeutics Holdings Inc.
				PTX-COVID19-B
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Stemirna Therapeutics Co Ltd
				SW-BIC-213
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Walvax
				AWcorna
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			4 trials in 3 countries		

		
		
			RNA
		

		
	
		
		
			
								Bharat Biotech
				iNCOVACC
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			4 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								CanSino
				Convidecia
			
		
		
	
	
		This vaccine is approved.	

	Approved in 10 countries		
			14 trials in 6 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								CanSino
				Convidecia Air
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			5 trials in 4 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Gamaleya
				Sputnik Light
			
		
		
	
	
		This vaccine is approved.	

	Approved in 26 countries		
			7 trials in 3 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Gamaleya
				Sputnik V
			
		
		
	
	
		This vaccine is approved.	

	Approved in 74 countries		
			25 trials in 8 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Janssen (Johnson & Johnson)
				Jcovden
			
		
		
	
	
		This vaccine is approved.	

	Approved in 113 countries		
			26 trials in 25 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Mahidol University; Butantan Institute; Mount Sinai
				NDV-HXP-S
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			7 trials in 3 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Oxford/AstraZeneca
				Vaxzevria
			
		
		
	
	
		This vaccine is approved.	

	Approved in 149 countries		
			73 trials in 34 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								ReiThera
				GRAd-COV2
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			5 trials in 12 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Serum Institute of India
				Covishield (Oxford/ AstraZeneca formulation)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 49 countries		
			6 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Wantai
				DelNS1-2019-nCoV-RBD-OPT1
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			5 trials in 3 countries		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Airlangga University
				UNAIR Inactivated COVID-19 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Bharat Biotech
				Covaxin
			
		
		
	
	
		This vaccine is approved.	

	Approved in 14 countries		
			16 trials in 2 countries		

		
		
			Inactivated
		

		
	
		
		
			
								China National Biotec Group Company Limited
				Omicron COVID-19 Vaccine (Vero Cell)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			3 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Chinese Academy of Medical Sciences
				Inactivated (Vero Cells)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			8 trials in 4 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Health Institutes of Turkey
				Turkovac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			8 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								KM Biologics Co Ltd
				KD-414
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			7 trials in 2 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Organization of Defensive Innovation and Research
				FAKHRAVAC (MIVAC)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			3 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Research Institute for Biological Safety Problems (RIBSP)
				QazVac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			3 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Shenzhen Kangtai Biological Products Co
				KCONVAC
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			7 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Shifa Pharmed Industrial Co
				COVIran Barekat
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			6 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinopharm (Beijing)
				Covilo
			
		
		
	
	
		This vaccine is approved.	

	Approved in 93 countries		
			39 trials in 18 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Sinopharm (Wuhan)
				Inactivated (Vero Cells)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 2 countries		
			9 trials in 7 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				CoronaVac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 56 countries		
			42 trials in 10 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				Trivalent COVID-19 Vaccine (Vero Cell), Inactivated
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Valneva
				VLA2001
			
		
		
	
	
		This vaccine is approved.	

	Approved in 33 countries		
			9 trials in 4 countries		

		
		
			Inactivated
		

		
	
		
		
			
								Valneva
				VLA2101
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
	72 Vaccines in Phase 2 Clinical Trials	
		
			
								Adimmune Corporation
				AdimrSC-2f
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Biological E Limited
				BECOV2B
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Biological E Limited
				BECOV2C
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Biological E Limited
				BECOV2D
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Center for Genetic Engineering and Biotechnology (CIGB)
				CIGB-669
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Clover
				SCB-2020S
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Human Stem Cell Institute Russia
				Betuvax-CoV-2
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Instituto Finlay de Vacunas Cuba
				Soberana 01
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Kentucky Bioprocessing
				KBP-201
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Livzon Pharmaceutical Group Inc
				V-01-351/V-01D
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Medigen
				MVC-COV1901(Beta)
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				ICC Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				SII B.1.351
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				SII B.1.617.2
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Novavax
				SII Bivalent
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Research Institute for Biological Safety Problems
				QazCoVac-P
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Shanghai Zerun Biotechnology, Walvax Biotechnology
				202-CoV
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			6 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Shanghai Zerun Biotechnology, Walvax Biotechnology
				202a-CoV
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Sinocelltech
				SCTV01E-1
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 0 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								St. Petersburg Research Institute of Vaccines and Sera
				Recombinant subunit vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Tuebingen
				CoVac-1
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								University Medical Center Groningen
				AKS-452X
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								University of Saskatchewan
				COVAC-2
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			5 trials in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								Vector State Research Center of Virology and Biotechnology
				Aurora-CoV
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								SpyBiotech
				RBD SARS-CoV-2 HBsAg VLP
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			VLP
		

		
	
		
		
			
								The Scientific and Technological Research Council of Turkey
				SARS-CoV-2 VLP Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			VLP
		

		
	
		
		
			
								The Scientific and Technological Research Council of Turkey
				SARS-CoV-2 VLP Vaccine Alpha Variant
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			VLP
		

		
	
		
		
			
								VBI Vaccines Inc
				VBI-2902a
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			VLP
		

		
	
		
		
			
								AnGes
				AG0301-COVID19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Entos Pharmaceuticals Inc
				Covigenix VAX-001
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								GeneOne Life Science, Inc.
				GLS-5310
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			4 trials in 2 countries		

		
		
			DNA
		

		
	
		
		
			
								Nykode Therapeutics
				VB10.2129
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Nykode Therapeutics
				VB10.2210
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Takis
				COVID-eVax
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Arcturus Therapeutics Inc
				ARCT-165
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Arcturus Therapeutics Inc
				LUNAR-COV19/ARCT-021
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			6 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Chulalongkorn University
				ChulaCov19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			5 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								Chulalongkorn University
				ChulaCov19-BNA159 mRNA Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								CSPC ZhongQi Pharmaceutical Technology
				SYS6006
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Elixirgen Therapeutics Inc
				EXG-5003
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								EyeGene Inc
				EG-COVID-003
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gennova Biopharmaceuticals Limited
				HGCO19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								GreenLight Biosciences, Inc.
				GLB-COV2-043
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								ImmunityBio Inc
				AAHI-SC2 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								ImmunityBio Inc
				AAHI-SC3 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1073
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1283
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1283.211
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162a1
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b2 (B.1.1.7 + B.1.617.2)
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 4 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b2 (B.1.1.7)
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 4 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b2 (B.1.617.2)
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 4 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b3
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b5 Bivalent (WT/OMI BA.2)
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162c2
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								SENAI CIMATEC
				HDT-301
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Takeda
				TAK-919 (Moderna formulation)
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Biocad
				BCD-250
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Gamaleya
				Gam-COVID-Vac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 1 country		
			2 trials in 0 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								ImmunityBio Inc
				hAd5-Covid-19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			7 trials in 2 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Institute of Vaccines and Medical Biologicals
				COVIVAC
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Shenzhen Geno-Immune Medical Institute
				LV-SMENP
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Universitätsklinikum Hamburg-Eppendorf
				MVA-SARS-2-ST
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			3 trials in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Vaxart
				VXA-CoV2-1.1-S
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Aivita Biomedical Inc
				AV-COVID-19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			4 trials in 2 countries		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Cellid Co
				AdCLD-CoV19
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			5 trials in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								City of Hope Medical Center
				COH04S1
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Chumakov Center
				KoviVac
			
		
		
	
	
		This vaccine is approved.	

	Approved in 3 countries		
			5 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Laboratorio Avi-Mex
				Recombinant NDV Vectored Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac Biotech (Hong Kong) Limited
				COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				CoronaVac Omicron Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Sinovac
				CoronaVac Trivalent Vaccine
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
	66 Vaccines in Phase 1 Clinical Trials	
		
			
								ACM Biolabs
				ACM-001
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Baiya Phytopharm Co Ltd
				Baiya SARS-CoV-2 Vax 1 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Baiya Phytopharm Co Ltd
				Baiya SARS-CoV-2 Vax 2
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Emergex Vaccines Holding Ltd
				PepGNP-SARSCoV2
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								HK inno.N Corporation
				IN-B009
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Intravacc B.V.
				Avacc 10
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Livzon Pharmaceutical Group Inc
				V-01
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Livzon Pharmaceutical Group Inc
				V-01-351/V-01-B5
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Livzon Pharmaceutical Group Inc
				V-01/V-01-B5
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								National Vaccine and Serum Institute
				GEN2-Recombinant COVID-19 Vaccine (CHO Cells)
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								OSE Immunotherapeutics
				CoVepiT
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								SK Bioscience Co Ltd
				NBP2001
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Speransa Therapeutics
				PRIME-2-CoV_Beta
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 2 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								University of Melbourne
				DoCo-Pro-RBD-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								University of Saskatchewan
				COVAC-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 3 countries		

		
		
			Protein Subunit
		

		
	
		
		
			
								US Army Medical Research and Development Command
				SpFN COVID-19 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								VaxForm
				CoV2-OGEN1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								VBI Vaccines Inc
				VBI-2901a
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			VLP
		

		
	
		
		
			
								VBI Vaccines Inc.
				VBI-2901e
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			VLP
		

		
	
		
		
			
								Imam Abdulrahman Bin Faisal University
				Almansour-001
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 0 countries		

		
		
			DNA
		

		
	
		
		
			
								Providence Health & Services
				CORVax12
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Scancell
				COVIDITY
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Symvivo
				bacTRL-Spike
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			DNA
		

		
	
		
		
			
								The University of Hong Kong
				SARS-CoV-2 DNA Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			DNA
		

		
	
		
		
			
								University of Sydney
				COVIGEN
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			DNA
		

		
	
		
		
			
								AIM Vaccine Co., Ltd.
				LVRNA010
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								GlaxoSmithKline
				CoV2 SAM (LNP)
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								GlaxoSmithKline
				CV0501
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 3 countries		

		
		
			RNA
		

		
	
		
		
			
								GlaxoSmithKline
				CV2CoV
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gritstone Bio, Inc.
				GRT-R910
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gritstone bio, Inc.
				GRT-R912
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gritstone bio, Inc.
				GRT-R914
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Gritstone bio, Inc.
				GRT-R918
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								HDT Bio
				HDT-301
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Jiangsu Rec-Biotechnology
				RH109
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			3 trials in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1230
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 3 countries		

		
		
			RNA
		

		
	
		
		
			
								Moderna
				mRNA-1273.351
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								MRC/UVRI and LSHTM Uganda Research Unit
				LNP-nCOV saRNA-02 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				BNT162b4
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								Pfizer/BioNTech
				qIRV + bivalent BNT162b2 (original/Omi BA.4/BA.5)
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								RVAC Medicines
				RVM-V001
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Suzhou Abogen Biosciences
				ABO-CoV.617.2
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Suzhou Abogen Biosciences
				ABO1009-DP
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			2 trials in 2 countries		

		
		
			RNA
		

		
	
		
		
			
								University of Melbourne
				MIPSCo-mRNA-RBD-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								VLP Therapeutics Japan
				VLPCOV-01
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Walvax Biotechnology
				RQ3013
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			2 trials in 0 countries		

		
		
			RNA
		

		
	
		
		
			
								AMMS
				Ad5-nCoV
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Ankara City Hospital Bilkent
				CoVacHGMix
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Cellid Co
				AdCLD-CoV19-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								CyanVac LLC
				CVXGA1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								EnGeneIC
				COVID-19-EDV
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								McMaster University
				Ad5-triCoV/Mac
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								McMaster University
				ChAd-triCoV/Mac
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								NIAID
				ChAdV68-S
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								NIAID
				SAM-LNP-S
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Tetherex Pharmaceuticals Corporation
				SC-Ad6-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Universitatsklinikum Hamburg-Eppendorf
				MVA-SARS-2-S
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Vaxart
				VXA-CoV2-1
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Meissa Vaccines Inc
				MV-014-212
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Shenzhen Geno-Immune Medical Institute
				Covid-19/aAPC
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								The University of Hong Kong
				DelNS1-nCoV-RBD LAIV
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Eva Pharma
				EgyVax Vaccine Candidate
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Kocak Farma
				Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								National Research Centre Egypt
				Covi Vax
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								Osve Pharmaceutical Company
				OSVID-19
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
		
		
			
								The Scientific and Technological Research Council of Turkey
				Adjuvanted Inactivated Vaccine
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Inactivated
		

		
	
	12 Vaccines are No Longer Progressing	
		
			
								Curevac
				CVnCoV
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			9 trials in 12 countries		

		
		
			RNA
		

		
	
		
		
			
								Genexine
				GX-19
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			7 trials in 1 country		

		
		
			DNA
		

		
	
		
		
			
								Israel Institute for Biological Research (IIBR)
				Brilife
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			4 trials in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Oxford/AstraZeneca
				AZD2816
			
		
		
	
	
		This vaccine has reached Phase 3 trials.	

			
			2 trials in 2 countries		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Icosavax
				IVX-411
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			Protein Subunit
		

		
	
		
		
			
								Merck Sharp & Dohme Corp
				V591
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 3 countries		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Sanofi Pasteur
				MRT5500
			
		
		
	
	
		This vaccine has reached Phase 2 trials.	

			
			2 trials in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Altimmune Inc
				AdCOVID
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Non Replicating Viral Vector
		

		
	
		
		
			
								Imperial
				LNP-nCoVsaRNA
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			RNA
		

		
	
		
		
			
								Institut Pasteur
				COVID-19-101
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 2 countries		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Merck Sharp & Dohme Corp
				V590
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Replicating Viral Vector
		

		
	
		
		
			
								Queensland
				Sclamp
			
		
		
	
	
		This vaccine has reached Phase 1 trials.	

			
			1 trial in 1 country		

		
		
			Protein Subunit
		

		
	
			
	